Douglas Emmett provided its 2026 outlook, forecasting fully diluted FFO per share between $1.39 and $1.43 and diluted net income per common share between negative $0.20 and negative $0.16. The company reported second-quarter revenue of $257 million, up from $252 million a year earlier, while same-property cash net operating income decreased 1.2%. Management highlighted the acquisition of the Bedford Collection, a five-building medical office portfolio in Beverly Hills, for $260 million, in which Douglas Emmett holds a 13.3% equity stake. The office occupancy guidance range was lowered to 75% to 77%, a change attributed solely to including Studio Plaza in full-year assumptions now that the property has moved from development to in-service. Executives noted that higher market interest rates are expected to more than offset operational improvements, and they are evaluating strategies to manage interest rate exposure.
Douglas Emmett Inc2026 FFO guidance below expectations and net income loss forecast, with higher interest rates expected to offset operational improvements.
